Goldman Sachs
MBX

Goldman Sachs’s MBX Biosciences MBX Stock Holding History

Goldman Sachs’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.7M Buy
457,945
+126,007
+38% +$4.29M ﹤0.01% 2791
2025
Q4 		$10.5M Sell
331,938
-26,183
-7% -$635K ﹤0.01% 3056
2025
Q3 		$6.27M Buy
+358,121
New +$4.79M ﹤0.01% 3445
2025
Q2 		– Sell
-15,168
Closed -$112K – 6525
2025
Q1 		$112K Sell
15,168
-19,659
-56% -$208K ﹤0.01% 5766
2024
Q4 		$642K Sell
34,827
-16,173
-32% -$345K ﹤0.01% 5100
2024
Q3 		$1.32M Buy
+51,000
New +$1.17M ﹤0.01% 4444

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Goldman Sachs's MBX Position: Q1 2026 in Review

Goldman Sachs increased its MBX Biosciences (MBX) stake by 38% in Q1 2026, buying an estimated $4.29M and bringing the position to 457,945 shares worth $13.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2791.

Goldman Sachs first reported a position in MBX in Q3 2024 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Goldman Sachs held 457,945 shares of MBX Biosciences worth $13.7M as of Q1 2026.
  • Goldman Sachs bought 126,007 MBX Biosciences shares in Q1 2026, an estimated $4.29M.
  • MBX Biosciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2791 holding.
  • Goldman Sachs first reported a position in MBX Biosciences in Q3 2024 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.